Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women

American Journal of Epidemiology

Volumn 153, Issue 7, 2001, Pages 673-679

  Roest, Mark ^a,b   Van Der Schouw, Yvonne T ^a   Grobbee, Diederick E ^a   Tempelman, Mariëlle J ^b   De Groot, Philip G ^b   Sixma, Jan J ^b   Banga, Jan Dirk ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular diseases; Genotype; Hyperhomocysteinemia; Mortality; Postmenopause; Women

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NETHERLANDS; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGE DISTRIBUTION; AGED; BASE SEQUENCE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MASS SCREENING; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MOLECULAR SEQUENCE DATA; NETHERLANDS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROBABILITY; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0035313486     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.7.673     Document Type: Article

References (41)

1. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
2. Association between plasma homocysteine concentrations and extracranial carotidartery stenosis
3. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
4. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer
5. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells
6. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. (Letter)
7. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
8. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
9. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
10. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine and other risk factors for vascular disease
11. MTHFR association with arteriosclerotic vascular disease?
12. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
13. The DOM Project for the early detection of breast cancer, Utrecht, The Netherlands
14. Proportion of disease caused or prevented by a given exposure, trait or intervention
15. The factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women
16. Mendelian proportions in mixed population
17. The behavior of maximum likelihood estimates under non-standard conditions
18. The 677C→T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease
19. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
20. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
21. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation
22. Molecular variant of 5,10methylenetetrahydrofolate reductase is a risk factor of ischaemic heart disease in the Japanese population
23. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease. (Letter)
24. Methylenetetrahydrofolate reductase mutation and coronary artery disease
25. Methylenetetrahydrofolate reductase gene and coronary artery disease
26. Gene polymorphism of 5,10-methylenetetrahydrofolate reductase as a coronary risk factor
27. A common mutation in the methylenetetrahydrofolate gene and risk of coronary heart disease: Results among U.S. men
28. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: A case-control study
29. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene
30. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction
31. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
32. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine metabolism and late-onset vascular disease
33. Elevated total plasma homocysteine and 677C→T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. (Letter)
34. The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients
35. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
36. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes
37. Common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease
38. The VITA Project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism
39. The C677T MTHFR variant and the risk of venous thrombosis. (Letter)
40. International classification of diseases